Public-registry trials using PLS240 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 | Pathalys Pharma | Secondary Hyperparathyroidism | PHASE3 | 68 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →